ClinicalTrials.gov record
Completed Phase 2 Interventional

13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer

ClinicalTrials.gov ID: NCT00002586

Public ClinicalTrials.gov record NCT00002586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ASSESSMENT OF INTERMEDIATE ENDPOINT BIOMARKERS TO 13-CIS RETINOIC ACID WITH OR WITHOUT ALPHA TOCOPHEROL OR OBSERVATION

Study identification

NCT ID
NCT00002586
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Colorado, Denver
Other
Enrollment
96 participants

Conditions and interventions

Interventions

  • 13-cis retinoic acid Drug
  • Tocopherol Dietary Supplement

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1992
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
May 14, 2020

1993 – 2005

United States locations

U.S. sites
4
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010
National Jewish Center for Immunology and Respiratory Medicine Denver Colorado 80206
Lung Cancer Institute Denver Colorado 80218
Veterans Affairs Medical Center - Denver Denver Colorado 80220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2020 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002586 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →